DocGo Inc. Business Acquisition, Pro Forma Net Income (Loss)
DocGo Inc. (DCGO) reported Business Acquisition, Pro Forma Net Income (Loss) of $11.09 million for the 12-month period ending 2023-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss · last filed 2025-02-27
- DocGo Inc. business acquisition, pro forma net income (loss) for the quarter ending 2023-12-31 was $7.99M.
- DocGo Inc. business acquisition, pro forma net income (loss) for the quarter ending 2023-09-30 was $4.63M.
- DocGo Inc. business acquisition, pro forma net income (loss) for the quarter ending 2023-06-30 was $1.34M.
- DocGo Inc. business acquisition, pro forma net income (loss) for the quarter ending 2023-03-31 was -$2.88M.
- DocGo Inc. business acquisition, pro forma net income (loss) for fiscal 2023 was $11.09M, a 76.39% decline from fiscal 2022.
- DocGo Inc. business acquisition, pro forma net income (loss) for fiscal 2022 was $46.96M, a 7.31% increase from fiscal 2021.
- DocGo Inc. business acquisition, pro forma net income (loss) for fiscal 2021 was $43.76M.
| Period end | Business Acquisition, Pro Forma Net Income (Loss) 3 month | Business Acquisition, Pro Forma Net Income (Loss) 6 month | Business Acquisition, Pro Forma Net Income (Loss) 9 month | Business Acquisition, Pro Forma Net Income (Loss) 12 month |
|---|---|---|---|---|
| 2023-12-31 | $7.99M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $12.62M derived: sum of 2 quarters · filed 2025-02-27 | $13.97M derived: sum of 3 quarters · filed 2025-02-27 | $11.09M 10-K · filed 2025-02-27 |
| 2023-09-30 | $4.63M 10-Q · filed 2024-11-07 | $5.97M derived: sum of 2 quarters · filed 2024-11-07 | $3.09M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $1.34M 10-Q · filed 2024-08-07 | -$1.54M 10-Q · filed 2024-08-07 | ||
| 2023-03-31 | -$2.88M 10-Q · filed 2024-05-08 | |||
| 2022-12-31 | $46.96M 10-K · filed 2025-02-27 | |||
| 2021-12-31 | $43.76M 10-K · filed 2024-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |